Polar Asset Management Partners’s Aspire Biopharma Warrant ASBPW Stock Holding History

Polar Asset Management Partners’s Portfolio ASBPW Stock Details ASBPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.52K	Hold	138,536	–	–	﹤0.01%	674
2025 Q4	$2.71K	Hold	138,536	–	–	﹤0.01%	664
2025 Q3	$3.88K	Hold	138,536	–	–	﹤0.01%	650
2025 Q2	$6.23K	Hold	138,536	–	–	﹤0.01%	581
2025 Q1	$10.1K	Hold	138,536	–	–	﹤0.01%	493
2024 Q4	$6.58K	Hold	138,536	–	–	﹤0.01%	639
2024 Q3	$5.86K	Hold	138,536	–	–	﹤0.01%	678
2024 Q2	$6.22K	Hold	138,536	–	–	﹤0.01%	661
2024 Q1	$4.17K	Hold	138,536	–	–	﹤0.01%	750
2023 Q4	$8.31K	Hold	138,536	–	–	﹤0.01%	700
2023 Q3	$7.02K	Hold	138,536	–	–	﹤0.01%	815
2023 Q2	$6.94K	Hold	138,536	–	–	﹤0.01%	902
2023 Q1	$5.79K	Hold	138,536	–	–	﹤0.01%	1011
2022 Q4	$11.1K	Hold	138,536	–	–	﹤0.01%	1060
2022 Q3	$15K	Hold	138,536	–	–	﹤0.01%	1203
2022 Q2	$24K	Buy	+138,536	New	+$30.1K	﹤0.01%	1166

Other funds holding ASBPW

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Polar Asset Management Partners's ASBPW Position: Q1 2026 in Review

Polar Asset Management Partners held its Aspire Biopharma Warrant (ASBPW) position steady in Q1 2026 at 138,536 shares worth $2.52K. The position accounts for ﹤0.01% of the portfolio, ranked #674.

Polar Asset Management Partners first reported a position in ASBPW in Q2 2022 and has held it in 16 quarters since. The position peaked at $24K in Q2 2022. 29 funds tracked by Wall St. Rank hold ASBPW as of Q1 2026.

Polar Asset Management Partners held 138,536 shares of Aspire Biopharma Warrant worth $2.52K as of Q1 2026.
Polar Asset Management Partners left its Aspire Biopharma Warrant share count unchanged in Q1 2026.
Aspire Biopharma Warrant made up ﹤0.01% of Polar Asset Management Partners's portfolio in Q1 2026, its #674 holding.
Polar Asset Management Partners first reported a position in Aspire Biopharma Warrant in Q2 2022 and has held it in 16 quarters since.
Polar Asset Management Partners's Aspire Biopharma Warrant position peaked at $24K in Q2 2022.
29 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q1 2026.

Based on Polar Asset Management Partners's 13F filing for Q1 2026, filed 15 May 2026.